PE20060462A1 - Combinacion farmaceutica que comprende derivados de benzoxazinona - Google Patents
Combinacion farmaceutica que comprende derivados de benzoxazinonaInfo
- Publication number
- PE20060462A1 PE20060462A1 PE2005000432A PE2005000432A PE20060462A1 PE 20060462 A1 PE20060462 A1 PE 20060462A1 PE 2005000432 A PE2005000432 A PE 2005000432A PE 2005000432 A PE2005000432 A PE 2005000432A PE 20060462 A1 PE20060462 A1 PE 20060462A1
- Authority
- PE
- Peru
- Prior art keywords
- compounds
- halogen
- salts
- alkyl
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Abstract
REFERIDA A UNA COMBINACION FARMACEUTICA QUE COMPRENDE: UNO O MAS COMPUESTOS DERIVADOS DE BENZOXAZINONA DE FORMULA 1, DONDE n ES 1 O 2; R1 ES H, HALOGENO, ALQUILO C1-C4, ENTRE OTROS; R2 ES H, HALOGENO, ALQUILO C1-C4, ENTRE OTROS; R3 ES ALQUILO C1-C4, OH, HALOGENO, ENTRE OTROS; Y AL MENOS OTRO PRINCIPIO ACTIVO DE FORMULA 2. DENTRO DE LOS PRINCIPIOS ACTIVOS DE FORMULA 2, SE ENCUENTRAN COMPUESTOS ANTICOLINERGICOS TALES COMO SALES DE TIOTROPIO, SALES DE OXITROPIO, SALES DE IPRATROPIO, ENTRE OTROS; COMPUESTOS INHIBIDORES DE PDE IV TALES COMO TEOFILINA, PUMAFENTINA, ENTRE OTROS; COMPUESTOS ESTEROIDES TALES COMO PREDNISOLONA, BECLOMETASONA, TRIAMCINOLONA, ENTRE OTROS; COMPUESTOS ANTAGONISTAS DE LTD4 TALES COMO MONTELUKAST, MN-001, ENTRE OTROS; Y COMPUESTOS INHIBIDORES DE EGFR. DICHA COMBINACION ES UTIL PARA EL TRATAMIENTO DE ENFERMEDADES DE LAS VIAS RESPIRATORIAS TALES COMO ENFISEMAS PULMONARES, FIBROSIS QUISTICA, BRONQUIECTASIAS, ENTRE OTRAS
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004019540A DE102004019540A1 (de) | 2004-04-22 | 2004-04-22 | Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen |
DE102004052987A DE102004052987A1 (de) | 2004-11-03 | 2004-11-03 | Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen |
EP05002496 | 2005-02-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20060462A1 true PE20060462A1 (es) | 2006-06-19 |
Family
ID=34966478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2005000432A PE20060462A1 (es) | 2004-04-22 | 2005-04-20 | Combinacion farmaceutica que comprende derivados de benzoxazinona |
Country Status (31)
Country | Link |
---|---|
EP (2) | EP2422786B1 (es) |
JP (1) | JP2007533683A (es) |
KR (2) | KR20130049840A (es) |
AR (1) | AR049262A1 (es) |
AT (1) | ATE539754T1 (es) |
AU (1) | AU2005235419B2 (es) |
BR (1) | BRPI0510080B8 (es) |
CA (1) | CA2559699C (es) |
CY (3) | CY1113890T1 (es) |
DK (2) | DK2422786T3 (es) |
EA (1) | EA013157B1 (es) |
EC (1) | ECSP066947A (es) |
ES (2) | ES2380370T3 (es) |
FI (1) | FIC20170005I1 (es) |
HU (1) | HUS1500058I1 (es) |
IL (2) | IL177685A (es) |
LT (1) | LTC1781298I2 (es) |
LU (1) | LU93066I2 (es) |
MY (1) | MY148945A (es) |
NL (1) | NL300779I2 (es) |
NO (2) | NO337714B1 (es) |
NZ (1) | NZ550797A (es) |
PE (1) | PE20060462A1 (es) |
PL (2) | PL1781298T4 (es) |
PT (2) | PT2422786E (es) |
SG (1) | SG152237A1 (es) |
SI (2) | SI2422786T1 (es) |
TW (2) | TWI374739B (es) |
UY (1) | UY28861A1 (es) |
WO (1) | WO2005102349A1 (es) |
ZA (1) | ZA200606624B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
US7220742B2 (en) | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
DE102004024452A1 (de) * | 2004-05-14 | 2005-12-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation von Betaagonisten |
US7923455B2 (en) * | 2005-01-28 | 2011-04-12 | Boehringer Ingelheim International Gmbh | Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic |
EP1855689A1 (en) * | 2005-02-16 | 2007-11-21 | Boehringer Ingelheim International GmbH | Pharmaceutical compositions comprising anticholinergics and etiprednol |
CN101208316B (zh) | 2005-08-15 | 2012-05-09 | 贝林格尔·英格海姆国际有限公司 | 制备β-模拟物的方法 |
US20070088030A1 (en) * | 2005-10-10 | 2007-04-19 | Barbara Niklaus-Humke | Aerosol formulations for the inhalation of beta-agonists |
US20070086957A1 (en) * | 2005-10-10 | 2007-04-19 | Thierry Bouyssou | Combination of medicaments for the treatment of respiratory diseases |
WO2007058971A2 (en) * | 2005-11-10 | 2007-05-24 | Bodor Nicholas S | Soft anticholinergic esters |
WO2007093608A1 (de) * | 2006-02-16 | 2007-08-23 | Boehringer Ingelheim International Gmbh | Arzneimittelkombinationen zur behandlung von atemwegserkrankungen |
US20090324510A1 (en) | 2006-08-07 | 2009-12-31 | Boehringer Ingelheim International Gmbh | Drug combinations for the treatment of respiratory tract diseases |
UY30543A1 (es) * | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de beta- agonistas |
UY30542A1 (es) * | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de agonistas beta |
JP2010507617A (ja) * | 2006-10-26 | 2010-03-11 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 呼吸器系及び消化器系障害の治療用の新規な医薬組成物 |
EP1921070A1 (de) | 2006-11-10 | 2008-05-14 | Boehringer Ingelheim Pharma GmbH & Co. KG | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung |
AU2009211523B2 (en) | 2008-02-07 | 2014-03-13 | Boehringer Ingelheim International Gmbh | Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production |
CA2733153C (en) | 2008-08-08 | 2016-11-08 | Boehringer Ingelheim International Gmbh | Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them |
JP2012509922A (ja) * | 2008-11-27 | 2012-04-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規粉末化結晶質吸入薬 |
WO2014016548A2 (en) * | 2012-07-27 | 2014-01-30 | Cipla Limited | Pharmaceutical composition |
EP2906218B1 (en) | 2012-10-09 | 2016-12-14 | Boehringer Ingelheim International GmbH | Beta-2-adrenoceptor agonist for the treatment of cough |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4460581A (en) * | 1982-10-12 | 1984-07-17 | Boehringer Ingelheim Kg | (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones |
US4570630A (en) | 1983-08-03 | 1986-02-18 | Miles Laboratories, Inc. | Medicament inhalation device |
AU591152B2 (en) | 1985-07-30 | 1989-11-30 | Glaxo Group Limited | Devices for administering medicaments to patients |
SE453566B (sv) | 1986-03-07 | 1988-02-15 | Draco Ab | Anordning vid pulverinhalatorer |
SG45171A1 (en) | 1990-03-21 | 1998-01-16 | Boehringer Ingelheim Int | Atomising devices and methods |
DE4318455A1 (de) | 1993-06-03 | 1994-12-08 | Boehringer Ingelheim Kg | Kapselhalterung |
DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
EP1305300A1 (de) | 2000-04-27 | 2003-05-02 | Boehringer Ingelheim Pharma GmbH & Co.KG | Neue, langwirksame betamimetika, verfahren zu deren herstellung und deren verwendung als arzneimittel |
HU226830B1 (en) | 2000-10-12 | 2009-11-30 | Boehringer Ingelheim Pharma | Thiotropium bromide monohydrate, method for producing the same and a pharmaceutical composition containing the same |
DK1401445T3 (da) | 2001-06-22 | 2006-11-27 | Boehringer Ingelheim Pharma | Krystallinsk anticholinergikum, fremgangsmåde til fremstilling af dette og anvendelse af dette til fremstilling af et lægemiddel |
DE10130371A1 (de) * | 2001-06-23 | 2003-01-02 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika |
ES2203327B1 (es) * | 2002-06-21 | 2005-06-16 | Almirall Prodesfarma, S.A. | Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen. |
DE10230751A1 (de) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern |
DE10246374A1 (de) * | 2002-10-04 | 2004-04-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
DE10253282A1 (de) * | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung |
-
2005
- 2005-04-18 JP JP2007508805A patent/JP2007533683A/ja active Pending
- 2005-04-18 SI SI200531904T patent/SI2422786T1/sl unknown
- 2005-04-18 PT PT111870382T patent/PT2422786E/pt unknown
- 2005-04-18 BR BRPI0510080A patent/BRPI0510080B8/pt active IP Right Grant
- 2005-04-18 SG SG200902525-5A patent/SG152237A1/en unknown
- 2005-04-18 DK DK11187038.2T patent/DK2422786T3/da active
- 2005-04-18 ES ES05739576T patent/ES2380370T3/es active Active
- 2005-04-18 NZ NZ550797A patent/NZ550797A/en unknown
- 2005-04-18 ES ES11187038.2T patent/ES2523518T3/es active Active
- 2005-04-18 KR KR1020137011141A patent/KR20130049840A/ko not_active Application Discontinuation
- 2005-04-18 WO PCT/EP2005/004073 patent/WO2005102349A1/de active Application Filing
- 2005-04-18 DK DK05739576.6T patent/DK1781298T3/da active
- 2005-04-18 EP EP11187038.2A patent/EP2422786B1/de active Active
- 2005-04-18 EP EP05739576A patent/EP1781298B1/de active Active
- 2005-04-18 SI SI200531488T patent/SI1781298T1/sl unknown
- 2005-04-18 PL PL05739576T patent/PL1781298T4/pl unknown
- 2005-04-18 AU AU2005235419A patent/AU2005235419B2/en active Active
- 2005-04-18 AT AT05739576T patent/ATE539754T1/de active
- 2005-04-18 CA CA2559699A patent/CA2559699C/en not_active Expired - Fee Related
- 2005-04-18 PL PL11187038T patent/PL2422786T3/pl unknown
- 2005-04-18 EA EA200601846A patent/EA013157B1/ru active Protection Beyond IP Right Term
- 2005-04-18 KR KR1020067024528A patent/KR101287460B1/ko active IP Right Grant
- 2005-04-18 PT PT05739576T patent/PT1781298E/pt unknown
- 2005-04-19 UY UY28861A patent/UY28861A1/es not_active Application Discontinuation
- 2005-04-20 MY MYPI20051739A patent/MY148945A/en unknown
- 2005-04-20 PE PE2005000432A patent/PE20060462A1/es active IP Right Grant
- 2005-04-21 TW TW101108945A patent/TWI374739B/zh active
- 2005-04-21 TW TW094112735A patent/TWI372056B/zh active
- 2005-04-22 AR ARP050101601A patent/AR049262A1/es not_active Application Discontinuation
-
2006
- 2006-08-08 ZA ZA2006/06624A patent/ZA200606624B/en unknown
- 2006-08-24 IL IL177685A patent/IL177685A/en active IP Right Grant
- 2006-10-23 EC EC2006006947A patent/ECSP066947A/es unknown
- 2006-11-02 NO NO20065060A patent/NO337714B1/no active Protection Beyond IP Right Term
-
2012
- 2012-03-26 CY CY20121100308T patent/CY1113890T1/el unknown
-
2013
- 2013-05-26 IL IL226562A patent/IL226562A0/en unknown
-
2014
- 2014-11-07 CY CY20141100925T patent/CY1115719T1/el unknown
-
2015
- 2015-12-01 NL NL300779C patent/NL300779I2/nl unknown
- 2015-12-01 HU HUS1500058C patent/HUS1500058I1/hu unknown
- 2015-12-01 LT LTPA2015043C patent/LTC1781298I2/lt unknown
-
2016
- 2016-05-09 LU LU93066C patent/LU93066I2/fr unknown
- 2016-12-01 NO NO2016022C patent/NO2016022I2/no unknown
-
2017
- 2017-01-13 FI FIC20170005C patent/FIC20170005I1/fi unknown
- 2017-04-20 CY CY2017014C patent/CY2017014I1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20060462A1 (es) | Combinacion farmaceutica que comprende derivados de benzoxazinona | |
NO20082643L (no) | Isokinolinaminopyrazolderivater, deres fremstilling og anvendelse som farmasoytiske midler for behandling av kreft | |
NO20074620L (no) | Spiroheterocykliske forbindelser og deres anvendelse som medikamenter | |
PE20081362A1 (es) | DERIVADOS MORFOLINO PIRIMIDINA COMO INHIBIDORES DE mTOR QUINASA Y PI3K | |
BRPI0510414A (pt) | uso de derivados de quinolina substituìdos para o tratamento de doenças micobacterianas resistentes a fármacos | |
AR049711A1 (es) | Compuestos heterociclicos condensados como inhibidores de la aldosterona sintasa; composiciones farmaceuticas que los contienen y su uso en la preparacion de un medicamento para el tratamiento o prevencion de enfermedades relacionadas con el hiperaldosterismo y por una liberacion excesiva de cortiso | |
NO20073730L (no) | Amidderivater | |
MX2015016416A (es) | Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades. | |
MX2015016344A (es) | Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades. | |
BR0317572A (pt) | Benzoxazinas e seus derivados como inibidores de pi3ks | |
NO20072978L (no) | Nye betuinderivater, preparat derav og anvendelse derav | |
NO20062370L (no) | Amidderivater | |
NO20073853L (no) | Faste, oralt applikerbare farmasoytiske administreringsformer inneholdende nvaroksaban med modifisert frigivelse | |
AR068768A1 (es) | Derivados de tetrahidroquinolina para tratar trastornos por estres post - traumatico | |
BR112015029401A2 (pt) | derivados pirazolo-pirrolidin-4-ona e seu uso no tratamento de doenças | |
AR072962A1 (es) | Derivados de pirimidin-4-ona sustituidos | |
NO20084049L (no) | Forbindelser med forsterket ampa receptor og anvendelse derav i medisin | |
PE20070708A1 (es) | Formulacion en aerosol para inhalacion de beta-agonistas | |
PE20080607A1 (es) | Formulacion en aerosol para la inhalacion de beta-agonistas | |
EA200971086A1 (ru) | Фармацевтические композиции и способ лечения шизофрении | |
NO20092764L (no) | Isosorbid mononitrat derivater for behandling av okular hypertensjon | |
BR112015022385A2 (pt) | droga para uma doença respiratória | |
MA33563B1 (fr) | 5-(3,4-dichloro-phényl)-n-(2-hydroxy-cyclohexyl)-6-(2,2,2-trifluoro-éthoxy)-nicotinamide et ses sels utilisés comme agents augmentant le cholestérol hdl | |
UY29739A1 (es) | Derivados de amidas o sales farmacéuticamente aceptables de los mismos, procesos de preparaciones farmacéuticas conteniéndolos y aplicaciones | |
US9096585B2 (en) | Antiviral compounds and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |